EDUARDO CHULUYAN ; CARLOS DAVIO; NELSON DUSETTI ; NICOLÁS FRAUNHOFFER ; MARÍA NOÉ GARCIA; JUAN GARONA ; BETINA GONZÁLEZ; FLORENCIA GOTTARDO; DANIEL GRASSO; JUAN IOVANNA; GUSTAVO KOHAN; PAUL EDUARDO LADA; OSCAR MAZZA; MARTÍN MONTE; DANIELA PAPADEMETRIO ; MARÍA EUGENIA PASQUALINI ; ANA SAHORES; PATRICIA SANTOFIMIA; AGUSTÍN YANEFF

The mRNA vaccine for the treatment of pancreatic cancer is here to stay

MEDICINA (BUENOS AIRES); Lugar: Buenos Aires; Año: 2023

BALSA, LUCIA M.; SOLERNÓ, LUISINA M.; RODRIGUEZ, MARIA R.; PARAJÓN-COSTA, BEATRIZ S.; GONZALEZ-BARÓ, ANA C.; ALONSO, DANIEL F.; GARONA, JUAN; LEÓN, IGNACIO E.

Cu(II)-acylhydrazone complex, a potent and selective antitumor agent against human osteosarcoma: Mechanism of action studies over in vitro and in vivo models

CHEMICO-BIOLOGICAL INTERACTIONS; Año: 2023 vol. 384

CARDAMA, GEORGINA A.; BUCCI, PAULA L.; LEMOS, JESÚS S.; LLAVONA, CANDELA; BENAVENTE, MICAELA A.; HELLMÉN, EVA; FARA, MARÍA LAURA; MEDRANO, EDUARDO; SPITZER, EDUARDO; DEMARCO, IGNACIO A.; SABELLA, PATRICIA; GARONA, JUAN; ALONSO, DANIEL F.

In Silico and In Vitro Evaluation of Bevacizumab Biosimilar MB02 as an Antitumor Agent in Canine Mammary Carcinoma

Animals; Año: 2023 vol. 13

SOBOL, NATASHA T.; SOLERNO, LUISINA M.; LLAVONA, CANDELA; ALONSO, DANIEL F.; GARONA, JUAN

Vasopressin Analog [V4Q5]dDAVP Exerts Cooperative Anticancer Effects in Combination With Low-Dose 5-Fluorouracil on Aggressive Colorectal Cancer Models

World Journal of Oncology; Año: 2023 vol. 14 p. 540 - 550

SOLERNÓ, LUISINA M.; SOBOL, NATASHA T.; GOTTARDO, MARÍA F.; CAPOBIANCO, CARLA S.; FERRERO, MAXIMILIANO R.; VÁSQUEZ, LILIANA; ALONSO, DANIEL F.; GARONA, JUAN

Propranolol blocks osteosarcoma cell cycle progression, inhibits angiogenesis and slows xenograft growth in combination with cisplatin-based chemotherapy

Scientific Reports; Año: 2022 vol. 12

SOBOL, NATASHA T.; SOLERNÓ, LUISINA M.; BELTRAN, BRADY; VASQUEZ, LILIANA; RIPOLL, GISELLE V.; GARONA, JUAN; ALONSO, DANIEL F.

Anticancer activity of repurposed hemostatic agent desmopressin on AVPR2‑expressing human osteosarcoma

Experimental and Therapeutic Medicine; Año: 2021

SEGATORI, VALERIA I.; GARONA, JUAN; CALIGIURI, LORENA; BIZZOTTO, JUAN; LAVIGNOLLE, ROSARIO; TORO, AYELÉN; SANCHIS, PABLO; SPITZER, EDUARDO; KROLEWIECKI, ALEJANDRO; GUERÓN, GERALDINE; ALONSO, DANIEL FERNANDO

Effect of Ivermectin and Atorvastatin on Nuclear Localization of Importin Alpha and Drug Target Expression Profiling in Host Cells from Nasopharyngeal Swabs of SARS-CoV-2- Positive Patients

Viruses; Lugar: Basilea; Año: 2021

RIPOLL, GISELLE V.; PIFANO, MARINA; GARONA, JUAN; ALONSO, DANIEL F.

Comment on ?Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer?

Frontiers in oncology; Año: 2020

ISEAS, SOLEDAD; ROCA, ENRIQUE L.; O´CONNOR, JUAN M.; ELETA, MARTIN; SANCHEZ-LUCEROS, ANALIA; DI LEO, DANIELA; TINELLI, MARCELO; FARA, MARIA L.; SPITZER, EDUARDO; DEMARCO, IGNACIO A.; RIPOLL, GISELLE V.; PIFANO, MARINA; GARONA, JUAN; ALONSO, DANIEL F.

Administration of the vasopressin analog desmopressin for the management of bleeding in rectal cancer patients: results of a phase I/II trial

INVESTIGATIONAL NEW DRUGS; Lugar: Berlin; Año: 2020

GOTTARDO, MARIA F.; CAPOBIANCO, CARLA S.; SIDABRA, JOHANNA E.; GARONA, JUAN; PERERA, YASSER; PEREA, SILVIO E.; ALONSO, DANIEL F.; FARINA, HERNAN G.

Preclinical efficacy of CIGB-300, an anti-CK2 peptide, on breast cancer metastasic colonization

Scientific Reports; Año: 2020 vol. 10

GARONA, JUAN; PIFANO, MARINA; RIPOLL, GISELLE; ALONSO, DANIEL F.

Development and therapeutic potential of vasopressin synthetic analog [V4Q5]dDAVP as a novel anticancer agent

VITAMINS AND HORMONES SERIES; Año: 2020 vol. 113 p. 259 - 289

ALONSO, DANIEL F.; TURIC, ESTEBAN; GARONA, JUAN

Desmopressin in canine mammary carcinoma: Comments on the importance of the administration route

VETERINARY AND COMPARATIVE ONCOLOGY; Año: 2020

GARONA, JUAN; SOBOL, NATASHA T.; SOLERNÓ, LUISINA M.; ALONSO, DANIEL F.

Potential Use of Desmopressin During Hepatic Resection for Colorectal Liver Metastases*

JOURNAL OF SURGICAL RESEARCH; Año: 2019 vol. 237 p. 1 - 2

GARONA, JUAN; SOBOL, NATASHA T.; PIFANO, MARINA; SEGATORI, VALERIA I.; GOMEZ, DANIEL E.; RIPOLL, GISELLE V.; ALONSO, DANIEL F.

Preclinical Efficacy of [V4Q5]dDAVP, a Second Generation Vasopressin Analog, on Metastatic Spread and Tumor-Associated Angiogenesis in Colorectal Cancer

Cancer Research and Treatment; Año: 2019

JUAN GARONA; NATASHA SOBOL; DANIEL F. ALONSO

Impact of Perioperative Blood Transfusion on Survival Among Women With Breast Cancer: Potential Benefits of Blood-Saving Agent Desmopressin Use During Surgery

AMERICAN JOURNAL OF THERAPEUTICS; Lugar: Philadelphia; Año: 2018

PIFANO, MARINA; GARONA, JUAN; SOBOL, NATASHA T; ALBERTÓ, MARINA; ALONSO, DANIEL F; RIPOLL, GISELLE V

Search of vasopressin analogs with antiproliferative activity on small-cell lung cancer: drug design based on two different approaches

Future Medicinal Chemistry; Año: 2018 vol. 10 p. 879 - 894

CHEVALIER, MERARI T; GARONA, JUAN; SOBOL, NATASHA T; FARINA, HERNAN G; ALONSO, DANIEL F; ÁLVAREZ, VERA A

In vitro and in vivo evaluation of desmopressin-loaded poly( D,L -lactic-co-glycolic acid) nanoparticles for its potential use in cancer treatment

NANOMEDICINE; Año: 2018 vol. 13 p. 2835 - 2849

JUAN GARONA; NATASHA SOBOL; DANIEL F. ALONSO

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in colorectal cancer: potential use of perioperative desmopressin to reduce allogenic blood transfusion rates.

JOURNAL OF GASTROINTESTINAL SURGERY : OFFICIAL JOURNAL OF THE SOCIETY FOR SURGERY OF THE ALIMENTARY TRACT.; Lugar: Berlin; Año: 2017

MARINA PIFANO; JUAN GARONA; CARLA S. CAPOBIANCO; NAZARENO GONZALEZ; DANIEL F. ALONSO; GISELLE V. RIPOLL

Peptide Agonists of Vasopressin V2 Receptor Reduce Expression of Neuroendocrine Markers and Tumor Growth in Human Lung and Prostate Tumor Cells.

Frontiers in Oncology; Año: 2017 vol. 7

JUAN GARONA; MARINA PIFANO; MARIA B. PASTRIAN; DANIEL E. GOMEZ; GISELLE V. RIPOLL; DANIEL F. ALONSO

Addition of vasopressin synthetic analogue [V4Q5]dDAVP to standard chemotherapy enhances tumour growth inhibition and impairs metastatic spread in aggressive breast tumour models.

CLINICAL & EXPERIMENTAL METASTASIS; Lugar: Berlin; Año: 2016

JUAN GARONA; DANIEL F. ALONSO

Peri-operative biology in primary breast cancer: selective targeting of vasopressin type 2 receptor using desmopressin as a novel therapeutic approach

BREAST CANCER RESEARCH AND TREATMENT; Lugar: Berlin; Año: 2016

JUAN GARONA; DANIEL F. ALONSO

Urokinase Exerts Antimetastatic Effects by Dissociating Clusters of Circulating Tumor Cells ? Letter

CANCER RESEARCH; Lugar: Philadelphia; Año: 2016

FERNANDO BENAVENT; CARLA S. CAPOBIANCO; JUAN GARONA; STÉFANO M. CIRIGLIANO; YASSER PERERA; ALEJANDRO J. URTREGER; SILVIO E. PEREA; DANIEL F. ALONSO; HERNAN G. FARINA

CIGB-300, an anti-CK2 peptide, inhibits angiogenesis, tumor cell invasion and metastasis in lung cancer models.

LUNG CANCER; Lugar: Amsterdam; Año: 2016

WEINBERG RS; GRECCO MO ; FERRO GS ; SEIGELSHIFER DJ; PERRONI NV; TERRIER FJ; SÁNCHEZ-LUCEROS A; MARONNA E; SÁNCHEZ-MARULL R; FRAHM I; GUTHMANN MD; DI LEO D; SPITZER E; CICCIA GN; GARONA J.; PIFANO M.; TORBIDONI AV; GOMEZ DE; RIPOLL GV; GOMEZ RE; DEMARCO IA ; ALONSO DF

A phase II dose-escalation trial of perioperative desmopressin (1-desamino-8-d-arginine vasopressin) in breast cancer patients

Springerplus; Año: 2015

GARONA J.; PIFANO M.; ORLANDO U.; PATRIAN B.; IANUCCI N.; ORTEGA H.; PODESTÁ E.; GOMEZ D.E.; RIPOLL G. V.; ALONSO D.F.

The novel desmopressin analogue [V4Q5]dDAVP inhibits angiogenesis, tumour growth and metastases in vasopressin type 2 receptor-expressing breast cancer models

INTERNATIONAL JOURNAL OF ONCOLOGY; Lugar: Atenas; Año: 2015

GARONA J.; ALONSO D.F.

Reciprocal interactions between tumor and endothelial cells: effects of selective vasopressin V2 receptor peptide agonists

Cancer Cell & Microenvironment; Lugar: Texas; Año: 2014 vol. 1 p. 1 - 5

GARONA J.; PIFANO M.; GOMEZ D.E.; ALONSO D.F.; RIPOLL G. V.

Insight into the effect of the vasopressin analog desmopressin on lung colonization by mammary carcinoma cells in BALB/c mice

ANTICANCER RESEARCH; Año: 2014

PATRIAN B.; GUZMAN F.; GARONA J.; PIFANO M.; RIPOLL G. V.; CASCONE O.; CICCIA G.; ALBERICIO F.; GOMEZ D.E.; ALONSO D.F.; IANUCCI N.

Structure-activity relationship of 1-desamino-8-D-arginine vasopressin as an antiproliferative agent on human V2 receptor-expressing cancer cells

MOLECULAR MEDICINE REPORTS; Lugar: Atenas; Año: 2014 p. 2568 - 2572

RIPOLL G. V.; GARONA J.; PIFANO M.; FARINA H.; GOMEZ D.E.; ALONSO D.F.

Reduction of tumor angiogenesis induced by desmopressin in a breast cancer model

BREAST CANCER RESEARCH AND TREATMENT; Lugar: Berlin; Año: 2013 vol. 142 p. 9 - 18

ORLANDO U.; GARONA J.; RIPOLL G. V.; MALOBERTI P.; SOLANO A.; AVAGNINA A.; ALONSO D.F.; GOMEZ D.E.; PODESTÁ E.

The functional interaction between acyl-CoA synthetase 4, 5-lipooxygenase and cyclooxygenase-2 controls tumor growth: a novel therapeutic target

PLOS ONE; Lugar: San Francisco; Año: 2012 vol. 7 p. 1 - 14

ALONSO D.F.; RIPOLL G. V.; GARONA J.; IANUCCI N.; GOMEZ D.E.

Metastasis: Recent Discoveries and Novel Perioperative Treatment Strategies with Particular Interest in the Hemostatic Compound Desmopressin

CURRENT PHARMACEUTICAL BIOTECHNOLOGY; Lugar: Oak Park; Año: 2011 vol. 12 p. 1974 - 1980

IANUCCI N.; RIPOLL G. V.; GARONA J.; CASCONE O.; CICCIA G.; GOMEZ D.E.; ALONSO D.F.

Antiproliferative effect of 1-deamino-8-D-arginine vasopressin analogs on human breast cancer cells: impact of substitutions at the conformational peptide loop

Future Medicinal Chemistry; Año: 2011 vol. 3 p. 1987 - 1993

RIPOLL G. V.; GARONA J.; HERMO G.; GOMEZ D.E.; ALONSO D.F.

Effects of the synthetic vasopressin analog desmopressin in a mouse model of colon cancer

ANTICANCER RESEARCH; Año: 2010 vol. 30 p. 5049 - 5054